• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Prima Biomed Ltd

+ Add to Watchlist

YP1B:GR

0.766 EUR 0.008 1.03%

As of 02:10:46 ET on 09/23/2014.

Snapshot for Prima Biomed Ltd (YP1B)

Open: 0.765 Day's Range: 0.765 - 0.766 Volume: 0
Previous Close: 0.774 52wk Range: 0.592 - 1.400 1-Yr Rtn: -18.51%

Stock Chart for YP1B

No chart data available.
  • YP1B:GR 0.766
  • 1D
  • 1M
  • 1Y
0.774
Interactive YP1B Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for YP1B

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -0.0110
Est. PEG Ratio -
Market Cap (M EUR) 31.70
Shares Outstanding (M) 40.96
30 Day Average Volume 17
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/18/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for YP1B

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for YP1B

Prima Biomed Ltd is an Australian biotechnology company with a portfolio of products focused in the therapeutic area of cancer.

Marc VoigtChief Executive OfficerSharron GargoskyChief Technical Officer
Deanne MillerSecretary/General Counsel
More Company Profile & Key Executives for YP1B

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil